From Casetext: Smarter Legal Research

Chien v. Skystar Bio Pharmaceutical Co.

United States Court of Appeals, Second Circuit
May 26, 2010
378 F. App'x 109 (2d Cir. 2010)

Summary

holding that plaintiff had burden to plead fraudulent concealment in case where the defendant allegedly owed a fiduciary duty

Summary of this case from Dennany v. Knights of Columbus

Opinion

Nos. 08-3960-cv (L), 09-1407-cv (con.), 09-2806-cv (con.), 09-3535-cv (con.).

May 26, 2010.

Appeal from judgments of dismissal and orders of the United States District Court for the District of Connecticut (Mark R. Kravitz, Judge).

UPON DUE CONSIDERATION, IT IS HEREBY ORDERED, ADJUDGED, AND DECREED that the judgments and orders of the District Court be AFFIRMED.

Andrew Chien, New Haven, CT, pro se.

Timothy Herring, Cummings Lockwood LLC, Stamford, CT, for Defendants-Appellees.

PRESENT: JOSÉ A. CABRANES, ROBERT A. KATZMANN, Circuit Judges, and J. GARVAN MURTHA, District Judge.

The Honorable J. Garvan Murtha, Senior Judge of the United States District Court for the District of Vermont, sitting by designation.


SUMMARY ORDER

Plaintiff-appellant Andrew Chien ("plaintiff or "Chien"), pro se, commenced two separate proceedings against defendants-appellants Skystar Bio Pharmaceutical Co., Scott Cramer, Steve Lowe, and David Wassung (jointly, "defendants") alleging claims of securities fraud. The District Court dismissed both of plaintiffs complaints and issued sanctions against plaintiff, as well as his attorney from the first proceeding. Chien proceeded pro se in his second proceeding in the District Court and does so here as well. Plaintiff now appeals from (1) the District Court's judgments dismissing his complaints in both securities fraud proceedings; (2) the District Court's order denying plaintiffs motion to amend in the first proceeding and granting partially defendants' motion for sanctions against Chien; and (3) the District Court's order denying Chien's motion for sanctions and granting, in part, defendants' motion for sanctions in the second proceeding. We assume the parties' familiarity with the remaining facts, procedural history, and issues on appeal.

We review de novo the District Court's decision dismissing a complaint pursuant to Rule 12(b)(6). See Chambers v. Time Warner, `Inc., 282 F.3d 147, 152 (2d Cir. 2002). "To survive dismissal, [a] plaintiff must provide the grounds upon which his claim rests through factual allegations sufficient `to raise a right to relief above the speculative level.'" ATSI Comms., Inc. v. Shaar Fund, Ltd., 493 F.3d 87, 98 (2d Cir. 2007) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007)). When a plaintiff proceeds pro se, as here, we are "obliged to construe his pleadings liberally, particularly when they allege civil rights violations." McEachin v. McGuinnis, 357 F.3d 197, 200 (2d Cir. 2004).

We review the imposition of Rule 11 sanctions for "abuse of discretion." See, e.g., Corroon v. Reeve, 258 F.3d 86, 92 (2d Cir. 2001). "A district court has abused its discretion if it based its ruling on an erroneous view of the law or on a clearly erroneous assessment of the evidence, or rendered a decision that cannot be located within the range of permissible decisions." Sims v. Blot, 534 F.3d 117, 132 (2d Cir. 2008) (internal quotation marks, citations, and alterations omitted).

After conducting an independent review of the record and case law, we conclude, substantially for the reasons stated in the well-reasoned orders and judgments of the District Court, that the dismissal of plaintiffs complaint was free of error and that the District Court did not "abuse its discretion" in issuing moderate sanctions against plaintiff in light of the circumstances and facts on the record. See Chien v. Skystar Bio Pharm. Co., No. 3:09-cv-149, 2009 WL 2487983 (D.Conn. Aug.12, 2009); Chien v. Skystar Bio Pharm. Co., 623 F.Supp.2d 255 (D.Conn. 2009); Chien v. Skystar Bio Pharm. Co., 256 F.R.D. 67 (D.Conn. 2009); Chien v. Skystar Bio Pharm. Co., No. 3:07-cv-781, 2008 WL 4198511 (D.Conn. Sept.11, 2008); Chien v. Skystar Bio Pharm. Co., 566 F.Supp.2d 108 (D.Conn. 2008).

CONCLUSION

We have considered each of defendant's arguments on appeal and find them to be without merit.

For the reasons stated above, we AFFIRM the judgment of the District Court.


Summaries of

Chien v. Skystar Bio Pharmaceutical Co.

United States Court of Appeals, Second Circuit
May 26, 2010
378 F. App'x 109 (2d Cir. 2010)

holding that plaintiff had burden to plead fraudulent concealment in case where the defendant allegedly owed a fiduciary duty

Summary of this case from Dennany v. Knights of Columbus

finding that "a court may judicially notice prior pleadings, orders, judgments, and other items appearing in the court records of prior litigation that are related to the case before the [c]ourt" when deciding a Rule 12(b) motion

Summary of this case from Perry v. Gov't Emps. Ins. Co.

imposing partial attorney's fees and costs as a reasonable sanctions for a pro se litigant who "inflicted substantial costs on Defendants"

Summary of this case from Bailey v. Interbay Funding, LLC
Case details for

Chien v. Skystar Bio Pharmaceutical Co.

Case Details

Full title:Andrew CHIEN, Plaintiff-Appellant, v. SKYSTAR BIO PHARMACEUTICAL CO.…

Court:United States Court of Appeals, Second Circuit

Date published: May 26, 2010

Citations

378 F. App'x 109 (2d Cir. 2010)

Citing Cases

Wynn v. Phillips Lytle LLP

Therefore, in considering a res judicata defense, a court may judicially notice prior pleadings, orders,…

Wynn v. Cassara

Therefore, in considering a res judicata defense, a court may judicially notice prior pleadings, orders,…